. The long-term goal of this project is to develop novel dietary strategies for the control of human obesity, the most prevalent nutrition-related disease in America. The objective of this application is to identify isomer-specific mechanisms by which conjugated linoleic acid (CLA), fatty acid (FA)s found in beef, dairy foods, and dietary supplements that decrease adiposity in certain animals and humans, reduces the triglyceride (TG) content of human adipocytes. The central hypothesis for this proposal is that trans-10, cis-12 CLA activates lipid-borne signals that suppress peroxisome proliferator activated receptor (PPAR)-? activity, thereby reducing the uptake of glucose and FAs for TG synthesis. This hypothesis is based on our findings demonstrating that trans-10, cis-12 CLA, but not cis-9, trans-11 CLA, directly increases the ratio of saturated FAs to monounsaturated FAs, and activates proinflammatory signals that suppress PPAR? activity. These actions of CLA are dependent on mitogen-activated protein kinase / extracellular signal-regulated kinase kinase (MEK/ERK) and nuclear factor kappa B (NF?B) signaling. The rationale for this research is that once we understand how trans-10, cis-12 CLA reduces the TG content of human adipocytes and identify potential metabolic consequences, it's effective and safe use as a dietary supplement for controlling obesity can be evaluated effectively. To accomplish these objectives, the following specific aims will be examined in primary cultures of human (pre) adipocytes:
Aim #1. Identify the mechanism by which CLA regulates PPAR? in adipocytes;
Aim #2. Determine the role of NF?B and MEK/ERK signaling in preadipocytes and adipocytes in mediating CLA's suppression of PPAR?;
and Aim #3. Determine how CLA or its metabolites impact on signals that induce delipidation.
In Aim #1, we will examine CLA's effects on the transcription and stability of PPAR? target genes, PPAR? phosphorylation, ligand-induced activation of a PPRE reporter, and recruitment of PPAR?, co-activators, co-repressors, and basal transcription factors to endogenous PPAR? target genes.
In Aim #2, we will investigate the impact of chemical inhibitors and siRNAs targeting NF?B and MEK/ERK on the induction of our candidate cytokines and PPAR? target genes and on glucose and FA uptake and metabolism.
In Aim #3, we will examine CLA's isomer-specific effects on the synthesis of lipids and cell signals known to activate NFKB and/or MEK/ERK and cause delipidation. Relevance. The proposed studies are significant because they are expected to lead to an in-depth understanding of the mechanism of action of CLA isomers and to promote the development of novel and safe dietary strategies for weight loss. As a consequence, reductions in health problems and financial costs related to obesity would be expected.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK063070-09
Application #
8019990
Study Section
Cellular Aspects of Diabetes and Obesity Study Section (CADO)
Program Officer
Haft, Carol R
Project Start
2002-09-30
Project End
2013-06-30
Budget Start
2011-01-01
Budget End
2013-06-30
Support Year
9
Fiscal Year
2011
Total Cost
$286,052
Indirect Cost
Name
University of North Carolina Greensboro
Department
Nutrition
Type
Schools of Arts and Sciences
DUNS #
616152567
City
Greensboro
State
NC
Country
United States
Zip Code
27402
Shen, Wan; Baldwin, Jessie; Collins, Brian et al. (2015) Low level of trans-10, cis-12 conjugated linoleic acid decreases adiposity and increases browning independent of inflammatory signaling in overweight Sv129 mice. J Nutr Biochem 26:616-25
Shen, Wan; Martinez, Kristina; Chuang, Chia Chi et al. (2013) The phospholipase C inhibitor U73122 attenuates trans-10, cis-12 conjugated linoleic acid-mediated inflammatory signaling and insulin resistance in human adipocytes. J Nutr 143:584-90
Martinez, Kristina; Shyamasundar, Shruthi; Kennedy, Arion et al. (2013) Diacylglycerol kinase inhibitor R59022 attenuates conjugated linoleic acid-mediated inflammation in human adipocytes. J Lipid Res 54:662-70
Shen, Wan; Chuang, Chia-Chi; Martinez, Kristina et al. (2013) Conjugated linoleic acid reduces adiposity and increases markers of browning and inflammation in white adipose tissue of mice. J Lipid Res 54:909-22
Obsen, Thomas; Faergeman, Nils J; Chung, Soonkyu et al. (2012) Trans-10, cis-12 conjugated linoleic acid decreases de novo lipid synthesis in human adipocytes. J Nutr Biochem 23:580-90
Reardon, Meaghan; Gobern, Semone; Martinez, Kristina et al. (2012) Oleic acid attenuates trans-10,cis-12 conjugated linoleic acid-mediated inflammatory gene expression in human adipocytes. Lipids 47:1043-51
Schmidt, Soren F; Jorgensen, Mette; Sandelin, Albin et al. (2012) Cross-species ChIP-seq studies provide insights into regulatory strategies of PPARýý in adipocytes. Transcription 3:19-24
Schmidt, Søren F; Jørgensen, Mette; Chen, Yun et al. (2011) Cross species comparison of C/EBPα and PPARγ profiles in mouse and human adipocytes reveals interdependent retention of binding sites. BMC Genomics 12:152
Schmidt, Soren F; Mandrup, Susanne (2011) Gene program-specific regulation of PGC-1{alpha} activity. Genes Dev 25:1453-8
Martinez, Kristina; Kennedy, Arion; McIntosh, Michael K (2011) JNK inhibition by SP600125 attenuates trans-10, cis-12 conjugated linoleic acid-mediated regulation of inflammatory and lipogenic gene expression. Lipids 46:885-92

Showing the most recent 10 out of 22 publications